Netherton Syndrome Market Set to Expand During the Forecast Period (2026-2036) as Novel Therapies Enter Development Pipeline | DelveInsight

LAS VEGAS, May 19, 2026 /PRNewswire/ -- The Netherton syndrome market size is expected to grow during the forecast period (2026–2036), primarily driven by the launch of upcoming therapies such as QRX003 (Quoin Pharmaceuticals), BCX17725 (BioCryst Pharmaceuticals), ATR-12 (Azitra), and...